Fierce Pharma: Wegovy pill nears blockbuster quarter as Foundayo trails
The Wegovy pill took about $811m in Q3, well ahead of the $184m Lilly reported for Foundayo, though injectable Ozempic and Wegovy kept losing share to Mounjaro and Zepbound. Novo launched the pill in the UAE, UK and Germany before quarter-end and four more countries since.
Source: Fierce Pharma (4 Nov 2026).